CDKN2A and acute myeloid leukemia: Similarly, PRC2 epigenetically suppresses its target gene p16, thereby influencing the cellular lifespan in acute myeloid leukemia cells and mantle cell lymphoma cells (Martin-Perez et al., 2010; Fiskus et al., 2012).